3Nakao S,Yamaguchi M,Takamatsu H,et al.Relative erythroid hyperplasia in the bone marrow at diagonosis of aplastic amemia:a predictive marker for a favourable response to cyclosporine therapy.Br J Haematol,1996,92(2):318～323
4Young NS,Barret AJ.The treatment of severe acquired aplastic anemia.Blood,1995,85(12):3367～3377
5Ohara A,Kojima S,Hamajima N,et al.Myelodysplastic syndrome and acute myelogenous anemia.Blood,1997,90(3):1009～1013
2JUNI P, ALTMAN D G, Eger M. Assessing the quality of controlled clinical trails[J]. BMJ, 2001,323:42 -46.
3NORBERT FRICKHOFEN, HERMANN HEIMPEL, JOACHIM P. Kaltwasser and Hubert Schrezenmeier. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Clinical Observations, Interventions, and Thareuptic trails[J]. Blood, 2003,101:1236- 1241.
4GLOCKMAN E, ESPEROU-BOURDEAU H, BOOGAERTS A, et al. Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globlin with prednisone for treatment of severe aplasticanemia[J]. Blood, 1992, 10:2540--2546.
5FRICKHOFEN N, KALTWASSER J P. Immunosuppressive treatment of aplastic anemia: a prospective, randomized multicenter trail evaluating antilymphocyte globulin (ALG) versus AI.G and cyclosporin A[J]. Blut, 1998, 56:191--192.
6MOHER D, MSc. The CONSORT Guidelines: improving the quality of research. Consolidated standards of reporting trials. Interview by Bonnie Horrigan [J]. AlternTher Health Med,2002,8:103 -108.
